Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Spain
Summary - Supply Of The Humira® Medicine (Adalimumab) For The Continuation Of Current Treatments, Excluding The New Treatments (Doe) For All Osakidetza Service Organizations And Linked Health Centers.
Deadline - Mar 19, 2025
GT reference number - 104364046
Product classification - Pharmaceutical products
Address - Spain
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 104364046
Document Type - Tender Notices
Description - Description: Supply of the Humira® medicine (Adalimumab) for the continuation of the current treatments, excluding the new treatments (DOE) for all the Osakidetza service organizations and health centers of private and non -profit ownership, located in the autonomous community of Euskadi, within the framework provided for in article 30 of Law 8/1997, of June 26, of June 26 Euskadi, which signs a linking agreement with Osakidetza-Basque Health Service.local title:: Suministro del medicamento Humira® (adalimumab) para la continuación de los tratamientos actuales, excluyendo los nuevos tratamientos (DOE) para todas las organizaciones de servicios de Osakidetza y centros sanitarios vinculados
Gt Ref Id - 104364046
Deadline - Mar 19, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database